270. Clinical Outcomes of Ceftriaxone versus Penicillin G for Complicated Viridans Group Streptococci Bacteremia

MLA

Stephanie Wo, et al. “270. Clinical Outcomes of Ceftriaxone versus Penicillin G for Complicated Viridans Group Streptococci Bacteremia.” Open Forum Infectious Diseases, vol. 7, no. Suppl 1, Dec. 2020, p. S137. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8af3fb8b776b1051a958710d7aaa6f39&authtype=sso&custid=ns315887.

APA

Stephanie Wo, Yanina Dubrovskaya, Justin Siegfried, John Papadopoulos, & Shin-Pung Jen. (2020). 270. Clinical Outcomes of Ceftriaxone versus Penicillin G for Complicated Viridans Group Streptococci Bacteremia. Open Forum Infectious Diseases, 7(Suppl 1), S137.

Chicago

Stephanie Wo, Yanina Dubrovskaya, Justin Siegfried, John Papadopoulos, and Shin-Pung Jen. 2020. “270. Clinical Outcomes of Ceftriaxone versus Penicillin G for Complicated Viridans Group Streptococci Bacteremia.” Open Forum Infectious Diseases 7 (Suppl 1): S137. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8af3fb8b776b1051a958710d7aaa6f39&authtype=sso&custid=ns315887.